Rosell Costa; Rafael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rosell Costa; Rafael.The latest application filed is for "method for the detection of egfr mutations in blood samples".

Company Profile

0.0.16

Rosell Costa; Rafael - Badalona ES
Rosell Costa; Rafael - Barcelona ES

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For The Detection Of Egfr Mutations In Blood Samples App 20140113293 - Rosell Costa; Rafael ; et al.	2014-04-24
Molecular Biomarkers For Predicting Response To Tyrosine Kinase Inhibitors In Lung Cancer App 20120316187 - Rosell Costa; Rafael ; et al.	2012-12-13
Methods And Reagents For Predicting Clinical Outcome And Customizing Chemotherapy In Lung Cancer Patients App 20110142961 - Taron Roca; Miguel ; et al.	2011-06-16
BRCA1 mRNA EXPRESSION LEVELS PREDICT SURVIVAL IN BREAST CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY App 20110086355 - Taron Roca; Miguel ; et al.	2011-04-14
BRCA1 mRNA EXPRESSION PREDICTS SURVIVAL IN PATIENTS WITH BLADDER CANCER TREATED WITH NEOADJUVANT CISPLATIN-BASED CHEMOTHERAPY App 20110059459 - Taron Roca; Miguel ; et al.	2011-03-10
Method Of Predicting Survival Of A Non-small-cell Lung Cancer Patient To A Chemotherapeutic Treatment App 20100286187 - Rosell Costa; Rafael ; et al.	2010-11-11
Prognostic Molecular Markers for ET-743 Treatment App 20100267732 - Rosell Costa; Rafael ; et al.	2010-10-21
Method Of Determining A Chemotherapeutic Regime And Survival Expectancy For Non Small Cell Lung Cancer Based On Egfr/csf-1/ca Ix Expression App 20100167296 - Rosell Costa; Rafael ; et al.	2010-07-01
Method Of Determining The Time To Progression Of Non Small Cell Lung Cancer After Chemotherapy Based On Thioredoxin Expression App 20100167297 - Rosell Costa; Rafael ; et al.	2010-07-01
Method Of Determining A Chemotherapeutic Regimen For Non-small-cell Lung Cancer Based On Brca1 Expression App 20100009013 - ROSELL COSTA; Rafael ; et al.	2010-01-14
Method For The Detection Of Egfr Mutations In Blood Samples App 20100009360 - Rosell Costa; Rafael ; et al.	2010-01-14
Method For The Isolation Of Mrna From Formalin Fixed, Paraffin-embedded Tissue App 20090264641 - Rosell Costa; Rafael ; et al.	2009-10-22
Prognostic Molecular Markers App 20080293725 - Rosell Costa; Rafael ; et al.	2008-11-27
Assay device of XPD/ERCC2 gene polymorphisms for the correct administration of chemotherapy in lung cancer App 20080085518 - Rosell Costa; Rafael ; et al.	2008-04-10
Device for assaying polymorphisms of gene xpd/ercc2 for the correct administration of chemotherapy for lung cancer App 20060148736 - Rosell Costa; Rafael ; et al.	2006-07-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.